VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...

topiramate, phentermine, bupropion and/or naltrexone. The cohort comprised 105 participants (mean age, 45.2 years; 92.1% women; 80.6% white; mean BMI, 36.4 kg/m 2) enrolled in an 18-month ...